Logo image of CGBD

CARLYLE SECURED LENDING INC (CGBD) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:CGBD - US8722801029 - Common Stock

12.7 USD
+0.04 (+0.32%)
Last: 1/9/2026, 8:00:00 PM
12.7 USD
0 (0%)
After Hours: 1/9/2026, 8:00:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CGBD. CGBD was compared to 235 industry peers in the Capital Markets industry. CGBD has an average financial health and profitability rating. CGBD has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

CGBD had positive earnings in the past year.
CGBD had a negative operating cash flow in the past year.
In the past 5 years CGBD has always been profitable.
Each year in the past 5 years CGBD had a positive operating cash flow.
CGBD Yearly Net Income VS EBIT VS OCF VS FCFCGBD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

Looking at the Return On Assets, with a value of 2.82%, CGBD is in line with its industry, outperforming 53.62% of the companies in the same industry.
CGBD's Return On Equity of 6.06% is in line compared to the rest of the industry. CGBD outperforms 43.83% of its industry peers.
CGBD has a Return On Invested Capital (3.22%) which is in line with its industry peers.
The Average Return On Invested Capital over the past 3 years for CGBD is below the industry average of 7.14%.
Industry RankSector Rank
ROA 2.82%
ROE 6.06%
ROIC 3.22%
ROA(3y)4.34%
ROA(5y)4.2%
ROE(3y)9.37%
ROE(5y)9.03%
ROIC(3y)4.38%
ROIC(5y)4.06%
CGBD Yearly ROA, ROE, ROICCGBD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

With a decent Profit Margin value of 29.49%, CGBD is doing good in the industry, outperforming 75.74% of the companies in the same industry.
CGBD's Profit Margin has improved in the last couple of years.
With a decent Operating Margin value of 41.53%, CGBD is doing good in the industry, outperforming 74.89% of the companies in the same industry.
In the last couple of years the Operating Margin of CGBD has remained more or less at the same level.
Looking at the Gross Margin, with a value of 44.34%, CGBD is in line with its industry, outperforming 48.09% of the companies in the same industry.
In the last couple of years the Gross Margin of CGBD has remained more or less at the same level.
Industry RankSector Rank
OM 41.53%
PM (TTM) 29.49%
GM 44.34%
OM growth 3Y-3.76%
OM growth 5Y-1.44%
PM growth 3Y-26.26%
PM growth 5Y5.82%
GM growth 3Y-3.2%
GM growth 5Y-0.67%
CGBD Yearly Profit, Operating, Gross MarginsCGBD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

4

2. Health

2.1 Basic Checks

The number of shares outstanding for CGBD has been increased compared to 1 year ago.
CGBD has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, CGBD has an improved debt to assets ratio.
CGBD Yearly Shares OutstandingCGBD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CGBD Yearly Total Debt VS Total AssetsCGBD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

Based on the Altman-Z score of 0.57, we must say that CGBD is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.57, CGBD is in line with its industry, outperforming 41.70% of the companies in the same industry.
CGBD has a Debt/Equity ratio of 1.10. This is a high value indicating a heavy dependency on external financing.
CGBD has a Debt to Equity ratio of 1.10. This is comparable to the rest of the industry: CGBD outperforms 44.68% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF N/A
Altman-Z 0.57
ROIC/WACCN/A
WACCN/A
CGBD Yearly LT Debt VS Equity VS FCFCGBD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

CGBD has a Current Ratio of 2.31. This indicates that CGBD is financially healthy and has no problem in meeting its short term obligations.
CGBD has a Current ratio of 2.31. This is in the better half of the industry: CGBD outperforms 77.02% of its industry peers.
CGBD has a Quick Ratio of 2.31. This indicates that CGBD is financially healthy and has no problem in meeting its short term obligations.
CGBD has a better Quick ratio (2.31) than 77.02% of its industry peers.
Industry RankSector Rank
Current Ratio 2.31
Quick Ratio 2.31
CGBD Yearly Current Assets VS Current LiabilitesCGBD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

3

3. Growth

3.1 Past

The earnings per share for CGBD have decreased strongly by -21.05% in the last year.
Measured over the past 5 years, CGBD shows a small growth in Earnings Per Share. The EPS has been growing by 2.24% on average per year.
The Revenue has been growing slightly by 2.55% in the past year.
Measured over the past years, CGBD shows a small growth in Revenue. The Revenue has been growing by 1.00% on average per year.
EPS 1Y (TTM)-21.05%
EPS 3Y9.58%
EPS 5Y2.24%
EPS Q2Q%-22.45%
Revenue 1Y (TTM)2.55%
Revenue growth 3Y10.75%
Revenue growth 5Y1%
Sales Q2Q%13.59%

3.2 Future

CGBD is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -7.64% yearly.
CGBD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.13% yearly.
EPS Next Y-21.56%
EPS Next 2Y-11.84%
EPS Next 3Y-7.64%
EPS Next 5YN/A
Revenue Next Year11.9%
Revenue Next 2Y8%
Revenue Next 3Y4.13%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CGBD Yearly Revenue VS EstimatesCGBD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
CGBD Yearly EPS VS EstimatesCGBD Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

5

4. Valuation

4.1 Price/Earnings Ratio

CGBD is valuated cheaply with a Price/Earnings ratio of 7.70.
82.98% of the companies in the same industry are more expensive than CGBD, based on the Price/Earnings ratio.
CGBD is valuated cheaply when we compare the Price/Earnings ratio to 27.19, which is the current average of the S&P500 Index.
CGBD is valuated reasonably with a Price/Forward Earnings ratio of 8.17.
Based on the Price/Forward Earnings ratio, CGBD is valued cheaper than 84.26% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.88. CGBD is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 7.7
Fwd PE 8.17
CGBD Price Earnings VS Forward Price EarningsCGBD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CGBD Per share dataCGBD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

CGBD's earnings are expected to decrease with -7.64% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)3.43
EPS Next 2Y-11.84%
EPS Next 3Y-7.64%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 12.81%, CGBD is a good candidate for dividend investing.
CGBD's Dividend Yield is rather good when compared to the industry average which is at 6.39. CGBD pays more dividend than 82.13% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 1.94, CGBD pays a better dividend.
Industry RankSector Rank
Dividend Yield 12.81%

5.2 History

The dividend of CGBD has a limited annual growth rate of 1.13%.
CGBD has been paying a dividend for over 5 years, so it has already some track record.
CGBD has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)1.13%
Div Incr Years4
Div Non Decr Years4
CGBD Yearly Dividends per shareCGBD Yearly Dividends per shareYearly Dividends per share 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

136.52% of the earnings are spent on dividend by CGBD. This is not a sustainable payout ratio.
CGBD's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP136.52%
EPS Next 2Y-11.84%
EPS Next 3Y-7.64%
CGBD Yearly Income VS Free CF VS DividendCGBD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M
CGBD Dividend Payout.CGBD Dividend Payout, showing the Payout Ratio.CGBD Dividend Payout.PayoutRetained Earnings

CARLYLE SECURED LENDING INC

NASDAQ:CGBD (1/9/2026, 8:00:00 PM)

After market: 12.7 0 (0%)

12.7

+0.04 (+0.32%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)11-04 2025-11-04/amc
Earnings (Next)02-23 2026-02-23/amc
Inst Owners37.66%
Inst Owner Change0%
Ins Owners0.43%
Ins Owner Change0.67%
Market Cap925.83M
Revenue(TTM)245.01M
Net Income(TTM)72.24M
Analysts72.31
Price Target13.62 (7.24%)
Short Float %0.84%
Short Ratio1.13
Dividend
Industry RankSector Rank
Dividend Yield 12.81%
Yearly Dividend1.89
Dividend Growth(5Y)1.13%
DP136.52%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-4.11%
Min EPS beat(2)-5.68%
Max EPS beat(2)-2.53%
EPS beat(4)1
Avg EPS beat(4)-2.64%
Min EPS beat(4)-7.06%
Max EPS beat(4)4.72%
EPS beat(8)3
Avg EPS beat(8)-0.78%
EPS beat(12)6
Avg EPS beat(12)-0.15%
EPS beat(16)9
Avg EPS beat(16)3.56%
Revenue beat(2)0
Avg Revenue beat(2)-6.75%
Min Revenue beat(2)-10.46%
Max Revenue beat(2)-3.03%
Revenue beat(4)1
Avg Revenue beat(4)-5.25%
Min Revenue beat(4)-10.46%
Max Revenue beat(4)0.28%
Revenue beat(8)3
Avg Revenue beat(8)-3.15%
Revenue beat(12)4
Avg Revenue beat(12)-2.52%
Revenue beat(16)7
Avg Revenue beat(16)0.02%
PT rev (1m)0%
PT rev (3m)-7.56%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-6.78%
EPS NY rev (1m)-0.13%
EPS NY rev (3m)-3.17%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.65%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.35%
Valuation
Industry RankSector Rank
PE 7.7
Fwd PE 8.17
P/S 3.78
P/FCF N/A
P/OCF N/A
P/B 0.78
P/tB 0.78
EV/EBITDA N/A
EPS(TTM)1.65
EY12.99%
EPS(NY)1.55
Fwd EY12.24%
FCF(TTM)-2.23
FCFYN/A
OCF(TTM)-2.23
OCFYN/A
SpS3.36
BVpS16.36
TBVpS16.36
PEG (NY)N/A
PEG (5Y)3.43
Graham Number24.64
Profitability
Industry RankSector Rank
ROA 2.82%
ROE 6.06%
ROCE 4.07%
ROIC 3.22%
ROICexc 3.28%
ROICexgc 3.29%
OM 41.53%
PM (TTM) 29.49%
GM 44.34%
FCFM N/A
ROA(3y)4.34%
ROA(5y)4.2%
ROE(3y)9.37%
ROE(5y)9.03%
ROIC(3y)4.38%
ROIC(5y)4.06%
ROICexc(3y)4.5%
ROICexc(5y)4.2%
ROICexgc(3y)4.5%
ROICexgc(5y)4.2%
ROCE(3y)5.55%
ROCE(5y)5.14%
ROICexgc growth 3Y8.24%
ROICexgc growth 5Y2.47%
ROICexc growth 3Y8.2%
ROICexc growth 5Y2.45%
OM growth 3Y-3.76%
OM growth 5Y-1.44%
PM growth 3Y-26.26%
PM growth 5Y5.82%
GM growth 3Y-3.2%
GM growth 5Y-0.67%
F-Score2
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.26
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.31
Quick Ratio 2.31
Altman-Z 0.57
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)133.13%
Profit Quality(5y)1416.45%
High Growth Momentum
Growth
EPS 1Y (TTM)-21.05%
EPS 3Y9.58%
EPS 5Y2.24%
EPS Q2Q%-22.45%
EPS Next Y-21.56%
EPS Next 2Y-11.84%
EPS Next 3Y-7.64%
EPS Next 5YN/A
Revenue 1Y (TTM)2.55%
Revenue growth 3Y10.75%
Revenue growth 5Y1%
Sales Q2Q%13.59%
Revenue Next Year11.9%
Revenue Next 2Y8%
Revenue Next 3Y4.13%
Revenue Next 5YN/A
EBIT growth 1Y-6.64%
EBIT growth 3Y6.6%
EBIT growth 5Y-0.46%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-204.93%
FCF growth 3Y11.41%
FCF growth 5YN/A
OCF growth 1Y-204.93%
OCF growth 3Y11.41%
OCF growth 5YN/A

CARLYLE SECURED LENDING INC / CGBD FAQ

What is the ChartMill fundamental rating of CARLYLE SECURED LENDING INC (CGBD) stock?

ChartMill assigns a fundamental rating of 4 / 10 to CGBD.


What is the valuation status of CARLYLE SECURED LENDING INC (CGBD) stock?

ChartMill assigns a valuation rating of 5 / 10 to CARLYLE SECURED LENDING INC (CGBD). This can be considered as Fairly Valued.


What is the profitability of CGBD stock?

CARLYLE SECURED LENDING INC (CGBD) has a profitability rating of 5 / 10.


Can you provide the financial health for CGBD stock?

The financial health rating of CARLYLE SECURED LENDING INC (CGBD) is 4 / 10.


Is the dividend of CARLYLE SECURED LENDING INC sustainable?

The dividend rating of CARLYLE SECURED LENDING INC (CGBD) is 5 / 10 and the dividend payout ratio is 136.52%.